Scienture Holdings, Inc. financial data

Symbol
SCNX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2420 Brunello Trace, Lutz, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
TRxADE HEALTH, INC (to 8/28/2024), TRXADE GROUP, INC. (to 5/28/2021), XCELLINK INTERNATIONAL INC. (to 1/31/2014), Bluebird Exploration Co. (to 12/10/2008)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 159 % +136%
Quick Ratio 0.09 % -99.5%
Debt-to-equity 24.6 % -86.9%
Return On Equity 16.4 %
Return On Assets 13.2 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.58M shares
Common Stock, Shares, Outstanding 8.61M shares +951%
Entity Public Float 11.5M USD -32.3%
Common Stock, Value, Issued 86 USD +975%
Weighted Average Number of Shares Outstanding, Basic 2.37M shares +208%
Weighted Average Number of Shares Outstanding, Diluted 2.37M shares +0.45%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 64.9K USD -83.5%
Cost of Revenue 61K USD -82.7%
Research and Development Expense 1.25M USD
General and Administrative Expense 7.59M USD +916%
Operating Income (Loss) -15.6M USD -458%
Nonoperating Income (Expense) -6.13M USD -849%
Net Income (Loss) Attributable to Parent 4.56M USD +9.69%
Earnings Per Share, Basic -1.34 USD/shares +70.7%
Earnings Per Share, Diluted 15.1 USD/shares +70.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.5M USD +193%
Accounts Receivable, after Allowance for Credit Loss, Current 10.4K USD -98.8%
Inventory, Net 7.88K USD -99.7%
Assets, Current 7.26M USD +30.8%
Property, Plant and Equipment, Net 17.5K USD -93.9%
Operating Lease, Right-of-Use Asset 215K USD -81.9%
Intangible Assets, Net (Excluding Goodwill) 76.4M USD +708%
Goodwill 7.85M USD +53%
Assets 94.3M USD +335%
Accounts Payable, Current 2.9M USD +119%
Accrued Liabilities, Current 1.04M USD +170%
Contract with Customer, Liability, Current 996 USD -90%
Liabilities, Current 5.41M USD -40.5%
Operating Lease, Liability, Noncurrent 173K USD -82.3%
Other Liabilities, Noncurrent 777K USD -21.4%
Liabilities 9.13M USD -9.58%
Retained Earnings (Accumulated Deficit) -31.9M USD -48.1%
Stockholders' Equity Attributable to Parent 85.1M USD +636%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 85.1M USD +636%
Liabilities and Equity 94.3M USD +335%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.2M USD -994%
Net Cash Provided by (Used in) Financing Activities -13.9M USD -2140%
Net Cash Provided by (Used in) Investing Activities 27.4M USD +8133%
Common Stock, Shares Authorized 100M shares +1400%
Common Stock, Shares, Issued 8.61M shares +951%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.35M USD +3936%
Interest Paid, Excluding Capitalized Interest, Operating Activities 62.4K USD +4474%
Deferred Tax Assets, Valuation Allowance 5.94M USD +47.3%
Operating Lease, Liability 234K USD
Depreciation 500 USD -82.3%
Lessee, Operating Lease, Liability, to be Paid 283K USD
Operating Lease, Liability, Current 60.9K USD -75.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 73.1K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 83.5K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 48.5K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 56.9K USD
Deferred Tax Assets, Operating Loss Carryforwards 5.8M USD +43.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 48.6K USD
Operating Lease, Payments 13.6K USD
Additional Paid in Capital 117M USD +254%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 6.08M USD +50.8%
Interest Expense 1.23M USD +211%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%